Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes

BACKGROUND: Metabolic-associated fatty liver disease (MAFLD), formerly known as non-alcoholic fatty liver disease, is the leading cause of liver disease that can ultimately lead to cirrhosis. Identifying a screening marker for early diagnosis of MAFLD in patients with type 2 diabetes (T2D) can reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Samimi, Sahar, Rajabzadeh, Sahar, Rabizadeh, Soghra, Nakhjavani, Manouchehr, Nakhaei, Pooria, Avanaki, Foroogh Alborzi, Esteghamati, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275169/
https://www.ncbi.nlm.nih.gov/pubmed/35818084
http://dx.doi.org/10.1186/s40001-022-00731-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275169/
https://www.ncbi.nlm.nih.gov/pubmed/35818084
http://dx.doi.org/10.1186/s40001-022-00731-x

Ejemplares similares